ORIGINAL RESEARCH article

Front. Immunol.

Sec. T Cell Biology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1630599

The POSH scaffold protein is essential for signal coordination leading to CD8 T cell differentiation and survival

Provisionally accepted
Caitlyn  GuldenpfennigCaitlyn GuldenpfennigYue  GuanYue GuanBela  CersiBela CersiElida  LopezElida LopezEmma  TeixeiroEmma TeixeiroMark  DanielsMark Daniels*
  • NextGen Precision Health, Molecular Microbiology and Immunology, University of Missouri, Columbia, United States

The final, formatted version of the article will be published soon.

Upon antigen recognition, naive CD8 T cells must induce c-JUN N-terminal kinase (JNK), NF-κB, and Akt signaling to drive differentiation and generate a heterogeneous effector response. While the roles of these three pathways individually in mediating essential cellular responses for CD8 T cell differentiation are well established, the mechanisms of signal integration and crosstalk between these pathways to produce a diverse and heterogeneous response to infection remain poorly understood. Here, we establish the critical role of the Plenty of SH3 Domains (POSH) scaffold protein in coordinating signals from all three pathways to support CD8 T cell differentiation and fate. Using novel conditional T cell POSH knockout mouse models, we demonstrate that POSH is essential for the proper induction of the JNK, NF-κB, and Akt pathways. Furthermore, the absence of these signals via POSH leads to reduced differentiation into short-lived effector cells (SLECs), delayed proliferation, and decreased survival of memory precursors (MPECs) during contraction. Collectively, these data identify POSH as a key regulator of CD8 T cell fate and enhance our understanding of the complex mechanisms governing signal integration during CD8 T cell responses to infection.

Keywords: POSH, short-lived effector cell, memory precursors, Signal Transduction, NF-κB, Akt, JNK, CD8 T cell

Received: 18 May 2025; Accepted: 19 Jun 2025.

Copyright: © 2025 Guldenpfennig, Guan, Cersi, Lopez, Teixeiro and Daniels. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mark Daniels, NextGen Precision Health, Molecular Microbiology and Immunology, University of Missouri, Columbia, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.